Correction: Symptom Experienced Three Years after Liver Transplantation under Immunosuppression in Adults

Correction: Symptom Experienced Three Years after Liver Transplantation under Immunosuppression in Adults

Show other versions (1)

Bibliographic Details
Main Authors:	Chaoying Wang, Genshu Wang, Huimin Yi, Jianling Tan, Chi Xu, Xiaocui Fang, Yang Yang, Hua Li, Qier Chen, Guihua Chen
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859774/?tool=EBI

Similar Items

Correction: Symptom Experienced Three Years after Liver Transplantation under Immunosuppression in Adults.
by: Chaoying Wang, et al.
Published: (2013-01-01)

Symptom experienced three years after liver transplantation under immunosuppression in adults.
by: Chaoying Wang, et al.
Published: (2013-01-01)

Retraction: Symptom Experienced Three Years after Liver Transplantation under Immunosuppression in Adults.
by: PLOS ONE Editors
Published: (2019-01-01)

Application of immunosuppressants after liver transplantation for hepatocellular carcinoma
by: YANG Yang
Published: (2021-02-01)

Comparison of steroid-free immunosuppression and standard immunosuppression for liver transplant patients with hepatocellular carcinoma.
by: Tonghai Xing, et al.
Published: (2013-01-01)

Comprehensive comparison of three different immunosuppressive regimens for liver transplant patients with hepatocellular carcinoma: steroid-free immunosuppression, induction immunosuppression and standard immunosuppression.
by: Yuan-Yuan Liu, et al.
Published: (2015-01-01)

The Effect of Immunosuppressive Drugs on MDSCs in Transplantation
by: Fan Yang, et al.
Published: (2018-01-01)

A Comprehensive Review of Immunosuppression Used for Liver Transplantation
by: Sandeep Mukherjee, et al.
Published: (2009-01-01)

Prescription patterns and impacts of immunosuppressants on prognosis of liver transplantation
by: Ying-Yu Huang, et al.
Published: (2013)

Mesenchymal stem cells for treatment of steroid-resistant acute rejection after liver transplantation
by: Yingcai Zhang, et al.
Published: (2017-09-01)

Retraction: Comparison of Steroid-Free Immunosuppression and Standard Immunosuppression for Liver Transplant Patients with Hepatocellular Carcinoma.
by: PLOS ONE Editors
Published: (2019-01-01)

Retraction: Comprehensive Comparison of Three Different Immunosuppressive Regimens for Liver Transplant Patients with Hepatocellular Carcinoma: Steroid-Free Immunosuppression, Induction Immunosuppression and Standard Immunosuppression.
by: PLOS ONE Editors
Published: (2019-01-01)

Belatacept as salvage maintenance immunosuppression in a liver transplant recipient
by: Kyle Lang, et al.
Published: (2020-12-01)

Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma
by: Koen G. A. M. Hussaarts, et al.
Published: (2021-01-01)

Effect of Immunosuppressive Agents on Hepatocyte Apoptosis Post-Liver Transplantation.
by: Eu Jin Lim, et al.
Published: (2015-01-01)

Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients
by: Locke JE, et al.
Published: (2011-05-01)

Immunosuppression with prolonged-release tacrolimus in kidney or liver transplantation in India
by: Dinesh Khullar, et al.
Published: (2017-01-01)

Adherence to immunosuppressive therapy following liver transplantation: an integrative review
by: Ramon Antônio Oliveira, et al.

Clinical laboratory aspects of one-component immunosuppression during liver transplantation
by: M. Sh. Khubutia, et al.
Published: (2018-08-01)

Immunosuppressive Therapy in Immune-Mediated Liver Disease in the Non-Transplanted Patient
by: Anita Abhyankar, et al.
Published: (2013-12-01)

Discontinuation of immunosuppressive therapy after liver transplantation: an analysis of one case
by: LYU Guoyue
Published: (2013-09-01)

Impact of immunosuppressant therapy on new-onset diabetes in liver transplant recipients
by: Liu FC, et al.
Published: (2017-08-01)

Interest in Immunosuppression Withdrawal among Liver Transplant and Autoimmune Hepatitis Patients
by: Eden Sharabi, et al.
Published: (2021-04-01)

Inhibition of Autophagy Prolongs Recipient Survival Through Promoting CD8+ T Cell Apoptosis in a Rat Liver Transplantation Model
by: Xiaolong Chen, et al.
Published: (2019-06-01)

Sedative and Immunosuppressive Effects of Dexmedetomidine in Transplantation
by: Chen-Fang Lee, et al.
Published: (2021-08-01)

Diffusion MRI Findings in Encephalopathy Induced by Immunosuppressive Therapy after Liver Transplantation
by: Emanuele Tinelli, et al.
Published: (2020-01-01)

Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation
by: Ju-Yeun Lee, et al.
Published: (2014-06-01)

Factors associated with adherence of immunosuppressive therapy among liver and kidney transplant recipients
by: Ming-hui Shin, et al.
Published: (2012)

Immunosuppression and the Immune Response to Transplantation
by: David Ludwin, et al.
Published: (1993-01-01)

Immunosuppression for postcardiac transplant patients
by: Dhara Singh
Published: (2018-01-01)

Individualized Immunosuppressive Protocol of Liver Transplant Recipient Should be Made Based on Splenic Function Status
by: Ji-Yong Song, et al.
Published: (2016-01-01)

Symptom Experience and Related Predictors in Liver Transplantation Recipients
by: Xiao Chen, et al.
Published: (2021-02-01)

Platelets: A review of their function and effects in liver diseases
by: Haoqi Chen, et al.
Published: (2020-09-01)

Long-term use of everolimus as a component of immunosuppressive therapy in liver transplant recipients
by: M. Sh Khubutia, et al.
Published: (2016-01-01)

Use of Methylene Blue for Treatment of Severe Sepsis in an Immunosuppressed Patient after Liver Transplantation
by: Saravanan Ramamoorthy, et al.
Published: (2013-01-01)

Requirement of protocol biopsy before and after complete cessation of immunosuppression after liver transplantation
by: Yoshitomi, Mami
Published: (2010)

Clinical and economic impact of immunosuppressive therapy in the treatment and management of adult renal and liver transplantation
by: Muduma, Gorden
Published: (2018)

Efficacy and safety of basiliximab as initial immunosuppression in liver transplantation: A single center study
by: Mohamed Hashim, et al.
Published: (2020-09-01)

PRIMARY IMMUNOSUPPRESSION WITH TACROLIMUS AND AGE AT TRANSPLANTATION AS INDEPENDENT RISK FACTORS FOR THE DEVELOPMENT OF POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN CHILDREN UNDERGOING LIVER TRANSPLANTATION
by: GUTHERY, STEPHEN L.
Published: (2002)

Immunosuppression in lung transplantation: Changing perspectives
by: Unmil Shah, et al.
Published: (2021-01-01)